findmyKOL

Reuven Bromberg, MD

Basic profile

Miami Children's Hospital

ORCIDNone on fileNPI
RegionMiami, FL · SoutheastSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Reuven Bromberg is a Rheumatology/Immunology physician affiliated with Miami Children's Hospital. OpenAlex indexes 6 publications with 673 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Distinct works indexed by OpenAlex.

673citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
40companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

715 SW 73rd Ave
Miami, FL 331442635

Telephone

305-250-9998

Registry record last updated 27 Jun 2019.

View the NPPES registry record

Industry payments

40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    34%
    Folate Analog Metabolic Inhibitor14.8%
    Rasuvo43%Methotrexate38%Methotrexate Sodium11%Otrexup8%
    Part D<11 patients
    JAK inhibitor3.9%
    Xeljanz Xr69%Rinvoq31%
    Part D<11 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    21.9%
    Corticosteroid14.7%
    Prednisone100%
    Part D36 patients
    Antidiarrheal microorganisms3.3%
    Folic Acid100%
    Part D<11 patients

    + 2 more classes in this area

  • Nervous system

    19.3%
    Nonsteroidal Anti-inflammatory Drug10.4%
    Meloxicam83%Ibuprofen17%
    Part D<11 patients
    Gabapentinoids5.4%
    Gabapentin100%
    Part D15 patients

    + 1 more class in this area

Where care is delivered (Part B)4.3% facility · 95.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”